An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Clinical trial NCT01712347 · COMPLETED
Trial details
- NCT number
- NCT01712347
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-10-11
- Primary completion
- 2016-07-01
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.